Émilie Jigorel
Galapagos (France) · 21 works · 1,085 citations · h-index 10
Top works
- Differential Regulation of Sinusoidal and Canalicular Hepatic Drug Transporter Expression by Xenobiotics Activating Drug-Sensing Receptors in Primary Human Hepatocytes
- Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line
- FUNCTIONAL EXPRESSION OF SINUSOIDAL DRUG TRANSPORTERS IN PRIMARY HUMAN AND RAT HEPATOCYTES
- Binding Mode and Structure–Activity Relationships around Direct Inhibitors of the Nrf2–Keap1 Complex
- Physiological, pharmacological and clinical features of the multidrug resistance protein 2
- Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase
- Development of a small molecule that corrects misfolding and increases secretion of Z α1‐antitrypsin
- Utility of Drug Depletion-Time Profiles in Isolated Hepatocytes for Accessing Hepatic Uptake Clearance: Identifying Rate-Limiting Steps and Role of Passive Processes
- Optimization of 8-Hydroxyquinolines as Inhibitors of Catechol O -Methyltransferase
- Synthesis and Evaluation of Bicyclic Hydroxypyridones as Inhibitors of Catechol O -Methyltransferase
- The development of highly potent and selective small molecule correctors of Z α1-antitrypsin misfolding
- Inside Cover: Binding Mode and Structure–Activity Relationships around Direct Inhibitors of the Nrf2–Keap1 Complex (ChemMedChem 4/2014)
- Structure–Activity Relationship Guided Scaffold Hopping Resulted in the Identification of GLPG4970, a Highly Potent Dual SIK2/SIK3 Inhibitor
- 5:00 PM NEGATIVE MODULATION OF THE SYNAPTIC VESICLE PROTEIN (SV2A): A NEW PHARMACOLOGICAL TARGET FOR COGNITIVE DEFICIT ASSOCIATED WITH SCHIZOPHRENIA
- Negative modulation of the synaptic vesicle protein (SV2A): a new pharmacological target for cognitive deficit associated with schizophrenia
- Structure of keap1 kelch domain with (1S,2R)-2-{[(1S)-1-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-3,4-dihydroisoquinolin-2(1H)-yl]carbonyl}cyclohexanecarboxylic acid
- Transporteurs hépatiques de xénobiotiques : optimisation des modèles in vitro d’analyse et applications aux paramètres régulant leur expression et/ou activité
- Differential regulation of major hepatic drug transporter expression by xenobiotics activating drug receptors in primary human hepatocytes
- Structure of keap1 kelch domain with 2-{[(1S)-2-{[(1R,2S)-2-(1H-tetrazol-5-yl)cyclohexyl]carbonyl}-1,2,3,4-tetrahydroisoquinolin-1-yl]methyl}-1H-isoindole-1,3(2H)-dione